B2M (Human) CRISPR/Cas9 Lentivirus (Integrating)

Catalog #
78340
$795 *
Size: 500 µl x 2
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Beta-2 Microglobulin (B2M) is a required component of Major Histocompatibility Complex (MHC) class 1 molecules, which present peptide fragments from within the cell to cytotoxic T-cells as part of the adaptive immune system.

The B2M CRISPR/Cas9 Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a CRISPR/Cas9 gene driven by an EF1A promoter, along with 5 sgRNA (single guide RNAs) targeting human B2M driven by a U6 promoter (Figures 1 and 2).

The integrating lentivirus integrates randomly into the cellular genome to express both Cas9 and the sgRNA. Puromycin selection forces high expression levels of both Cas9 and the sgRNA, and can be used with the integrating lentivirus to quickly and easily achieve high knockdown efficiencies in a cell pool. Efficiencies will depend on the cell type and the gene of interest.

Figure 1. Schematic of the Lenti-vector used to generate the B2M CRISPR/Cas9 Lentivirus

Gene Target sgRNA Sequence
B2M AAGTCAACTTCAATGTCGGA
B2M CTGAATCTTTGGAGTACCTG
B2M GAGTAGCGCGAGCACAGCTA
B2M TCCTGAATTGCTATGTGTCT
B2M GAAGTTGACTTACTGAAGAA

Figure 2. List of sgRNA Sequences in the B2M CRISPR/Cas9 Lentivirus

Synonyms
B2M, beta-2-microglobulin, IMD43
Product Info
Storage and Usage
Citations
Species
Replication Incompetent HIV
Supplied As
Two vials (500 µl x 2) of lentivirus at a titer ≥1 x 106 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Formulation

The lentiviruses were produced from HEK293T cells in medium containing 90% DMEM + 10% FBS.